UBS Group reiterated their neutral rating on shares of Clariant (OTCMKTS:CLZNY) in a research note issued to investors on Wednesday, The Fly reports.
Other equities research analysts have also issued reports about the stock. JPMorgan Chase & Co. reiterated an underweight rating on shares of Clariant in a research report on Tuesday, June 15th. Morgan Stanley began coverage on shares of Clariant in a report on Friday, July 23rd. They issued an equal weight rating and a $21.40 price objective for the company. One analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. According to data from MarketBeat.com, Clariant currently has a consensus rating of Hold and an average price target of $21.40.
Shares of Clariant stock opened at $19.02 on Wednesday. Clariant has a 1 year low of $16.90 and a 1 year high of $25.50. The company has a 50 day simple moving average of $20.79 and a two-hundred day simple moving average of $21.12.
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals. It operates through the following segments: Care Chemicals; Catalysis; Natural Resources; Plastics and Coatings; and Corporate. The Care Chemicals segment comprises the industrial and consumer specialties business unit (BU), food additives as well as the industrial biotechnology business.
Featured Article: What is a stock portfolio tracker?
Receive News & Ratings for Clariant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clariant and related companies with MarketBeat.com's FREE daily email newsletter.